TY - JOUR
T1 - Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma
AU - Nozoe, T.
AU - Kohnoe, S.
AU - Ezaki, T.
AU - Kabashima, A.
AU - Maehara, Y.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2004/6
Y1 - 2004/6
N2 - Purpose: The aim of the current study was to find out a clinicopathologic significance of CD44v6 over-expression in esophageal squamous cell carcinoma (ESCC), which has not been elucidated fully. Methods: Immunohistochemical expression of CD44v6 was examined for 81 ESCCs. Correlation of CD44 over-expression with the clinicopathologic features were investigated. Results: Thirty-eight ESCCs (46.9%) had over-expression of CD44v6. The proportions of the incidence of lymph node metastasis (P = 0.039), lymphatic permeation (P = 0.003), and blood vessel invasion (P = 0.037) in ESCCs with over-expression of CD44v6 were significantly higher than those in ESCCs without over-expression of CD44v6. The stage of the tumor in ESCCs with over-expression of CD44v6 was significantly more advanced (P = 0.045). Survival rates of patients with ESCC with over-expression of CD44v6 were significantly worse (P = 0.0005). Moreover, CD44v6 over-expression (P = 0.048) as well as blood vessel invasion (P = 0.014) and stage of the tumor (P = 0.010) were factors independently associated withthe unfavorable prognosis of the patients with ESCC. Conclusions: Over-expression of CD44v6 can be an indicator of the malignant potential of ESCC.
AB - Purpose: The aim of the current study was to find out a clinicopathologic significance of CD44v6 over-expression in esophageal squamous cell carcinoma (ESCC), which has not been elucidated fully. Methods: Immunohistochemical expression of CD44v6 was examined for 81 ESCCs. Correlation of CD44 over-expression with the clinicopathologic features were investigated. Results: Thirty-eight ESCCs (46.9%) had over-expression of CD44v6. The proportions of the incidence of lymph node metastasis (P = 0.039), lymphatic permeation (P = 0.003), and blood vessel invasion (P = 0.037) in ESCCs with over-expression of CD44v6 were significantly higher than those in ESCCs without over-expression of CD44v6. The stage of the tumor in ESCCs with over-expression of CD44v6 was significantly more advanced (P = 0.045). Survival rates of patients with ESCC with over-expression of CD44v6 were significantly worse (P = 0.0005). Moreover, CD44v6 over-expression (P = 0.048) as well as blood vessel invasion (P = 0.014) and stage of the tumor (P = 0.010) were factors independently associated withthe unfavorable prognosis of the patients with ESCC. Conclusions: Over-expression of CD44v6 can be an indicator of the malignant potential of ESCC.
UR - http://www.scopus.com/inward/record.url?scp=3042807071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042807071&partnerID=8YFLogxK
U2 - 10.1007/s00432-004-0542-2
DO - 10.1007/s00432-004-0542-2
M3 - Article
C2 - 14872339
AN - SCOPUS:3042807071
SN - 0171-5216
VL - 130
SP - 334
EP - 338
JO - Journal of Cancer Research and Clinical Oncology
JF - Journal of Cancer Research and Clinical Oncology
IS - 6
ER -